JP Morgan Chase’s Molecular Partners MOLN Stock Holding History
Bought
Maintained
Sold
Other funds holding MOLN
JP Morgan Chase's MOLN Position: Q3 2026 in Review
JP Morgan Chase opened a new position in Molecular Partners (MOLN) in Q3 2026: 15 shares worth $61. The stake represents ﹤0.01% of the portfolio and ranks #7883 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in MOLN as recently as Q4 2023.
JP Morgan Chase first reported a position in MOLN in Q4 2023 and has held it in 2 quarters since. 7 funds tracked by Wall St. Rank hold MOLN as of Q3 2026.
- JP Morgan Chase held 15 shares of Molecular Partners worth $61 as of Q3 2026.
- Molecular Partners was a new JP Morgan Chase position in Q3 2026.
- Molecular Partners made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #7883 holding.
- JP Morgan Chase first reported a position in Molecular Partners in Q4 2023 and has held it in 2 quarters since.
- 7 funds tracked by Wall St. Rank held Molecular Partners as of Q3 2026.
Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.